Pentixapharm AG is a research-focused radiopharmaceutical and precision oncology company with operations focused on the preclinical, clinical development and manufacturing of the innovative theranostic drug peptide pair PentixaFor / PentixaTher and antibody-based pipeline. The clinical stage drugs specifically target the CXCR4 receptor, which is present in many rapidly progressing diseases. click apply for full job details